2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Placebo Eyedrops: new trials by email Literature Review of Placebo Eyedrops trials Research Report on Placebo Eyedrops
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control Atropine, Spectacles with HAL, Placebo Eyedrops - Myopia | Phase 3 | Recruiting | Jaeb Center for Health Research | 348 | 2026-06-01 | 2026-10-26 |
| Low-Dose Atropine for Treatment of Myopia Atropine, Placebo Eyedrops - Myopia | Phase 3 | Completed | Jaeb Center for Health Research | 200 | 2018-06-01 | 2026-07-31 |
| Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis 40 mg/mL Dexamethasone phosphate ophthalmic solution, Prednisolone Acetate (1%) Eyedrops, 100 mM sodium citrate buffer solution - Anterior Uveitis | Phase 3 | Completed | Eyegate Pharmaceuticals, Inc. | 193 | 2011-12-01 | 2013-03-29 |
Myopia (2) · Uveitis, Anterior (1)
Jaeb Center for Health Research (2) · Eyegate Pharmaceuticals, Inc. (1)
United States (3)
John D. Sheppard, M.D. (1) · Katherine A Lee, MD, PhD (1) · Katherine K Weise, OD, MBA (1) · Lori Ann F Kehler, OD (1) · Michael X Repka, MD, MBA (1)
U10EY011751 (1)